We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hydrogel-Embedded 3-D Scaffold Provides Superior Matrix for Culture of Captured Circulating Tumor Cells

By LabMedica International staff writers
Posted on 17 Aug 2015
Print article
Image: An integrated microfluidic chip design with an embedded three-dimensional hydrogel scaffold provides a transferable microenvironment for the recovery and longitudinal study of captured circulating tumor cells (Photo courtesy of Technology).
Image: An integrated microfluidic chip design with an embedded three-dimensional hydrogel scaffold provides a transferable microenvironment for the recovery and longitudinal study of captured circulating tumor cells (Photo courtesy of Technology).
Image: An integrated microfluidic chip design with an embedded three-dimensional hydrogel scaffold provides a transferable microenvironment for the recovery and longitudinal study of captured circulating tumor cells (Photo courtesy of Technology).
Image: An integrated microfluidic chip design with an embedded three-dimensional hydrogel scaffold provides a transferable microenvironment for the recovery and longitudinal study of captured circulating tumor cells (Photo courtesy of Technology).
Findings obtained by a proof-of-concept study suggested that isolated circulating tumor cells (CTCs) could be induced to grow on three-dimensional scaffolding embedded into a rehydrated hydrogel matrix where they were available for study, manipulation, and transplant.

Improvements in microfluidic technologies have substantially advanced cancer research by enabling the isolation of rare CTCs for diagnostic and prognostic purposes. However, the characterization of isolated CTCs has been limited due to the difficulty in recovering and growing isolated cells with high fidelity.

Investigators at Massachusetts General Hospital (Boston, USA) and their colleagues at Florida State University (Tallahassee, USA) and the University of Massachusetts (Amherst, USA) devised a strategy to substantially improve recovery of CTCs by using a three-dimensional scaffold integrated into a microfludic device. The transferable substrate was readily isolated after device operation for serial use in vivo as a transplanted tissue bed.

In a proof-of-concept study, a dry hydrogel scaffold was inserted into a capture chamber within the fluidic device and then rehydrated to fill the void volume of the capture chamber. Computational modeling was used to define different flow and pressure regimes that guided the conditions used to operate the chip. A cell suspension containing a prostate tumor cell line was used to verify that cancer cells would attach to the hydrogel matrix, which could be directly visualized under a microscope, and grow under these conditions.

Results published in the June 23, 2015, online edition of the journal Technology confirmed human prostate tumor cell attachment in the microfluidic scaffold chip, retrieval of the scaffold en masse, and serial implantation of the scaffold to a mouse model with preserved xenograft development.

"Companion models of circulating tumor cells can be a practical test bed to gain insight about new mutations and drug sensitivity of metastatic cells that can apply to patient care. This proof-of-concept study adds a new dimension to this important effort," said senior author Dr. Biju Parekkadan, assistant professor of surgery at Massachusetts General Hospital.

Related Links:

Massachusetts General Hospital
Florida State University
University of Massachusetts


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.